Evaluation of the Veriton SPECT/CT System

Not Applicable

Recruiting

• Conditions: Focus of Study is Comparison of 2 Types of Gamma Cameras
• Interventions: Diagnostic Test: Veriton SPECT/CT

• Registration Number: NCT04722185
• Lead Sponsor: Mayo Clinic

Brief Summary

The main purpose of this study is to evaluate a new type of gamma camera (the Veriton system) that provides a significant gain in system sensitivity and improved image quality compared to a conventional gamma camera that can achieve equal or better image quality than a standard SPECT/CT system.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-20
• Study First Submitted: 2021-01-20
• Study First Submitted QC: 2021-01-20
• Study First Posted: 2021-01-25
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-11
• Last Update Posted: 2024-03-13
• Primary Completion: 2026-01
• Study Completion: 2026-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Adults age 18 years or older.
• Currently scheduled to undergo a nuclear medicine exam.

Read More

Exclusion Criteria

• Individuals under 18 years of age.
• Unwilling/unable to sign an informed consent form.
• Unable to lie on a Veriton imaging table for up to 40 minutes.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Evaluation of the Veriton SPECT/CT system	Veriton SPECT/CT	To determine if the Veriton system can achieve equal or better image quality than a standard SPECT/CT system.

Primary Outcome Measures

Name	Time	Method
Image quality	1 year	Assessment of relative image quality between the Veriton system and a conventional gamma camera as a function of the type of nuclear medicine exam.

Trial Locations

Locations (1)

Mayo Clinic in Rochester; 🇺🇸 Rochester, Minnesota, United States